A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sovak, M. A. [1 ]
Lutzker, S. [1 ]
Guensch, L. [1 ]
Joyce, M. [1 ]
Schwartz, S. [1 ]
Wu, Y. [1 ]
Zheng, L. [1 ]
Aisner, J. [1 ]
机构：
[1] Canc Inst NJ, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18150
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)-Final report
    Sovak, M. A.
    Guensch, L.
    Joyce, P.
    Lutzker, S. G.
    Schwartz, S.
    Shih, W. J.
    Zheng, L.
    Aisner, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [3] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    [J]. LUNG CANCER, 2001, 33 (01) : 69 - 73
  • [4] Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer
    Kaira, K
    Takise, A
    Minato, K
    Iwasaki, Y
    Ishihara, S
    Takei, Y
    Tsuchiya, S
    Saito, R
    Sato, K
    Mori, M
    [J]. ANTI-CANCER DRUGS, 2005, 16 (04) : 455 - 460
  • [5] Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
    Park, Se Hoon
    Hong, Junshik
    Kim, Young Saing
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    [J]. LUNG CANCER, 2008, 62 (01) : 72 - 77
  • [6] A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
    Kunitoh, H
    Akiyama, Y
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Ohe, Y
    Kubota, K
    Tamura, T
    Shinkai, T
    Kodama, T
    Goto, K
    Niho, S
    Nishiwaki, Y
    Saijo, N
    [J]. LUNG CANCER, 2001, 33 (2-3) : 259 - 265
  • [7] A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC).
    Suzuki, R
    Taniguchi, H
    Kondoh, Y
    Shindoh, J
    Matsumoto, S
    Hiramatsu, T
    Gonda, H
    Baba, K
    Hasegawa, Y
    Shimokata, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 659S - 659S
  • [8] A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer
    Moore, T
    Patel, T
    Segal, M
    Thompson, J
    Zangmeister, J
    Larrimer, N
    Merriman, N
    Chidiac, T
    [J]. LUNG CANCER, 2005, 49 : S259 - S259
  • [9] Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer
    Koizumi, T
    Tsunoda, T
    Fujimoto, K
    Nomura, H
    Hirai, K
    Koyama, S
    Okada, K
    Kubo, K
    [J]. LUNG CANCER, 2001, 34 (01) : 125 - 131
  • [10] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    [J]. LUNG CANCER, 1998, 22 (02) : 139 - 148
12345